FDA Inspection 958048 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3005523343

The FDA completed an inspection of Biomat USA, Inc. on February 4, 2016 in Louisville, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 4, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Louisville, KY (United States)